235 results on '"Tadokoro, Tomoko"'
Search Results
2. Management of hepatocellular carcinoma, an important cause of death in Japanese autoimmune hepatitis patients
3. Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
4. Pegylated interferon therapy-related microRNA-6126 downregulates sodium taurocholate cotransporting polypeptide expression in hepatocytes
5. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study
6. Prognosis of probable autoimmune hepatitis patients: a single-center study in Japan
7. A Case of Idiopathic Portal Hypertension Diagnosed by Noninvasive Fibrosis Evaluation Using Elastography
8. Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg
9. A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response
10. The Treatment of Hepatocellular Carcinoma with Major Vascular Invasion.
11. 亜鉛製剤の長期投与中に急激な血球減少・末梢神経障害を生じた肝硬変患者の一例
12. Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival
13. Predictors of therapeutic response to peginterferon α‑2a and nucleos(t)ide analog combination therapy for HBeAg‑negative chronic hepatitis B: 1‑year follow‑up after treatment
14. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
15. Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report.
16. MicroRNAs and Nonalcoholic Steatohepatitis: A Review
17. Effectiveness of Edoxaban in Portal Vein Thrombosis Associated with Liver Cirrhosis
18. Ledipasvir/Sofosbuvir Is Effective for Relapsed Genotype 1b Hepatitis C Virus Patients after Achieving a Sustained Virological Response at Post-treatment Week 12 with Glecaprevir/Pibrentasvir
19. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy
20. Hepatocellular carcinoma treated with radical resection after endoscopic diagnosis of the extent of bile duct invasion: A case report
21. Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy
22. Usefulness of the Measurement of Psoas Muscle Volume for Sarcopenia Diagnosis in Patients with Liver Disease
23. Galectin-9 in Gastroenterological Cancer
24. Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy
25. Nutritional Support for Alcoholic Liver Disease
26. Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
27. Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
28. Correlation between serum galectin‐9 levels and liver fibrosis
29. Giant cutaneous metastasis from hepatocellular carcinoma
30. Clinical features of hepatic dysfunction caused by immune checkpoint inhibitors and treatment of refractory cases
31. Characterization of Cisplatin Effects in Lenvatinib-resistant Hepatocellular Carcinoma Cells
32. Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model
33. Antitumor Effect of Regorafenib on MicroRNA Expression in Hepatocellular Carcinoma Cell Lines
34. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
35. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case–control study
36. Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
37. Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA
38. Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up
39. Multimodal treatment involving molecular targeted agents and on‑demand transcatheter arterial chemoembolization for advanced hepatocellular carcinoma: A case report
40. Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study
41. Galectin‑9 suppresses the tumor growth of colon cancer in vitro and in vivo
42. MicroRNA Interference in Hepatic Host-Pathogen Interactions
43. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review
44. Association between microRNA‑527 and glypican‑3 in hepatocellular carcinoma
45. A case report of granulocyte colony-stimulating factor-producing hepatocellular carcinoma that recurred after long-term complete response
46. Identification of microRNA associated with the elimination of hepatitis C virus genotype 1b by direct‐acting antiviral therapies
47. L-carnitine reduces hospital admissions in patients with hepatic encephalopathy
48. Prognosis of Probable Autoimmune Hepatitis Patients in a Retrospective Cohort Study
49. Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
50. Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.